ReclutandoNCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Fase 3Eli Lilly and Company
Condiciones: Ulcerative Colitis, Obesity or Overweight
Sedes en Monterrey: Servicios de Oncología Médica Integral - Monterrey
Ver registro oficial ↗ReclutandoNCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Fase 3Eli Lilly and Company
Condiciones: Crohn's Disease, Obesity or Overweight
Sedes en Monterrey: Servicios de Oncología Médica Integral - Monterrey
Ver registro oficial ↗ReclutandoNCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Fase 3Amgen
Condiciones: Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Sedes en Monterrey: Cardiolink Clin Trials · Unidad Biomedica Avanzada Monterrey
Ver registro oficial ↗ReclutandoNCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Fase 3Novo Nordisk A/S
Condiciones: Obesity, Heart Failure
Sedes en Monterrey: Internal Medicine Clin Trials · Hospital Universitario Dr. José Eleuterio González_Monterrey · Hospital Zambrano Hellion TecSalud
Ver ficha informativaReclutandoNCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Fase 3Eli Lilly and Company
Condiciones: Overweight, Prediabetic State, Prehypertension
Sedes en Monterrey: Centro de investigación y control metabólico
Ver registro oficial ↗ReclutandoNCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Fase 3Amgen
Condiciones: Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Sedes en Monterrey: Cardiolink Clin Trials
Ver registro oficial ↗ReclutandoNCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Fase 3Eli Lilly and Company
Condiciones: Overweight, Obesity
Sedes en Monterrey: CEINV Salud · Clínica García Flores SC
Ver registro oficial ↗ReclutandoNCT06439277
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Fase 3Eli Lilly and Company
Condiciones: Obesity, Weight Gain
Sedes en Monterrey: Christus - Latam Hub Center of Excellence and Innovation S.C. · Clínica García Flores SC
Ver registro oficial ↗ReclutandoNCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Fase 3Eli Lilly and Company
Condiciones: Overweight, Obesity
Sedes en Monterrey: Cardiolink Clin Trials
Ver registro oficial ↗ReclutandoNCT07253285
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Fase 3Novo Nordisk A/S
Condiciones: Overweight, Obesity
Sedes en Monterrey: CHRISTUS - Latam Hub Excellence and Innovation Center · IECSI Centro de Investigación Clínica
Ver registro oficial ↗